The EU’s medicines regulator is investigating reports of a rare nerve-degenerating disorder in people who have received Astrazeneca’s Covid-19 vaccine, it announced this afternoon.
The watchdog has requested more detailed data on the cases from the company.
As part of a regular review of safety reports for the vaccine, Vaxzevria, the European Medicines Agency’s safety committee is analysing data provided on cases of Guillain-Barre syndrome in people who have had the Astrazeneca jab.
Guillain-Barre syndrome is a rare disorder in which your body's immune system attacks your nerves. Weakness and tingling in your extremities are usually the first symptoms. These sensations can quickly spread, eventually paralyzing your whole body.
The EMA is also looking into reports of heart inflammation with Pfizer-BioNTech’s vaccine, called Comirnaty, and Moderna’s shot, Reuters reported.
https://www.cityam.com/breaking-eu-...ne/?utm_source=dlvr.it&utm_medium=twitter
- Forums
- Breaking News
- COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED
COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-1666
-
- There are more pages in this discussion • 99,705 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online